By inhibiting HDAC activity, the tumor-suppressor Maspin and its mediated epigenetic changes facilitated to reprogram tumor cells toward a better-differentiated phenotype by targeting the p-Stat3/c-Myc signaling pathway and reducing inflammatory IL-6 and IL-8 (49). Here, SERPINB5 is linked to neoplasm.